Blow to Novartis as NICE rejects migraine drug Aimovig againAfter NICE rejected Novartis’ migraine prevention drug Aimovig in draft guidance issued in January, it was inundated with Share XBlow to Novartis as NICE rejects migraine drug Aimovig againhttps://pharmaphorum.com/news/blow-to-novartis-as-nice-rejects-migraine-drug-aimovig-again/
Science sector lauds UK’s visa scheme, but repeats no-deal Brexit warningBoris Johnson has ordered a new fast-track visa scheme to make it easier for top scientists to work Share XScience sector lauds UK’s visa scheme, but repeats no-deal Brexit warninghttps://pharmaphorum.com/news/science-sector-lauds-uks-visa-scheme-but-repeats-no-deal-brexit-warning/
Boris Johnson announces £1.8bn cash boost for NHSNew UK prime minister Boris Johnson has pledged a £1.8 billion cash injection for the NHS as he Share XBoris Johnson announces £1.8bn cash boost for NHShttps://pharmaphorum.com/news/boris-johnson-announces-1-8bn-cash-boost-for-nhs/
VPAS 2024: What should industry consider next time?The UK pharmaceutical industry is just getting to grips with working under two new approaches to regulating branded Share XVPAS 2024: What should industry consider next time?https://pharmaphorum.com/views-analysis-market-access/vpas-2024-what-should-industry-consider-next-time/
Market access round-up: the UK opens up to innovationWhen it comes to market access in the UK, the public’s eye has mostly been on the ongoing Share XMarket access round-up: the UK opens up to innovationhttps://pharmaphorum.com/views-and-analysis/market-access-roundup-the-uk-opens-up-to-innovation/
R&D Roundup: Pharma gets in on the biotech boomSome good news for the UK industry in turbulent times is always welcome, and several announcement this month Share XR&D Roundup: Pharma gets in on the biotech boomhttps://pharmaphorum.com/r-d/views-analysis-r-d/rd-roundup-pharma-gets-in-on-the-biotech-boom/
UK pharma patents up 20%, new report findsThe pharma industry saw double-digit growth in patent filings for the second year in a row in 2018, Share XUK pharma patents up 20%, new report findshttps://pharmaphorum.com/news/uk-pharma-patents-up-20-new-report-finds/
Pharma’s apprentice army is sculpting the futureA skills gap has been threatening to knock the shine off the UK biotechnology sector’s sparkling reputation for Share XPharma’s apprentice army is sculpting the futurehttps://pharmaphorum.com/r-d/views-analysis-r-d/pharmas-apprentice-army-is-sculpting-the-future/
Digital health market to top $379bn by 2024The digital health market is set to exceed $379 billion by 2024, according to a new report by Share XDigital health market to top $379bn by 2024https://pharmaphorum.com/news/digital-health-market-to-top-379bn-by-2024/
